3 completed, 2 unknown. 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 4 | 1 | Unknown 1 |
Follow Congenital Ichthyosis: new trials by email Literature Review of Congenital Ichthyosis trials Research Report on Congenital Ichthyosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploring Patient Reported Outcomes in Inherited Ichthyosis Questionnaires with patient reported outcome measures - Congenital Ichthyosis | Unknown | Maastricht University Medical Center | 20 | 2023-09-01 | 2023-11-08 | |
| Quality of Life in Middle-aged and Older Patients With Congenital Ichthyosis Qualitative interview - Congenital Ichthyosis | Completed | Maastricht University Medical Center | 20 | 2022-11-14 | 2025-10-01 | |
| Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children Secukinumab Injection, Ustekinumab Injection, Dupilumab Injection - Congenital Ichthyosis | Phase 4 | Unknown | National Medical Research Center for Children's Health, Russian Federation | 50 | 2021-03-01 | 2021-08-09 |
| A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis Isotretinoin, Vehicle - Congenital Ichthyosis | Phase 2 | Completed | LEO Pharma | 34 | 2019-12-03 | 2026-05-22 |
| A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis PAT-001, 0.1%, PAT-001, 0.2%, Vehicle for PAT-001 0.1% - Congenital Ichthyosis | Phase 2 | Completed | Patagonia Pharmaceuticals, LLC | 19 | 2017-03-08 | 2021-09-29 |
Ichthyosis Vulgaris (5) · Netherton Syndrome (1)
Congenital Abnormalities (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Ichthyosis (5) · Keratosis (5) · Skin Abnormalities (5) · Skin Diseases (5) · Skin Diseases, Genetic (5) · Skin and Connective Tissue Diseases (5) · Abnormalities, Multiple (1) · Ichthyosiform Erythroderma, Congenital (1) · Infant, Newborn, Diseases (1)
Isotretinoin (1) · Patient Reported Outcome Measures (1) · Surveys and Questionnaires (1) · Ustekinumab (1) · dupilumab (1) · secukinumab (1)
Maastricht University Medical Center (2) · LEO Pharma (1) · National Medical Research Center for Children's Health, Russian Federation (1) · Patagonia Pharmaceuticals, LLC (1)
Netherlands (2) · United States (2) · Australia (1) · Russia (1)
Antoni C Gostynski, MD, PhD (1) · Antoni H Gostynski, MD, PhD (1) · Zachary Rome, BS (1)